215 related articles for article (PubMed ID: 31377057)
1. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS
Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057
[TBL] [Abstract][Full Text] [Related]
2. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
3. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.
Finer G; Schnaper HW; Kanwar YS; Liang X; Lin HY; Hayashida T
Kidney Int; 2012 Sep; 82(5):525-36. PubMed ID: 22534961
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
[TBL] [Abstract][Full Text] [Related]
5. Activation of ERK1/2-mTORC1-NOX4 mediates TGF-β1-induced epithelial-mesenchymal transition and fibrosis in retinal pigment epithelial cells.
Kim SJ; Kim YS; Kim JH; Jang HY; Ly DD; Das R; Park KS
Biochem Biophys Res Commun; 2020 Aug; 529(3):747-752. PubMed ID: 32736702
[TBL] [Abstract][Full Text] [Related]
6. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.
Andrikopoulos P; Kieswich J; Pacheco S; Nadarajah L; Harwood SM; O'Riordan CE; Thiemermann C; Yaqoob MM
J Am Soc Nephrol; 2019 Jan; 30(1):33-49. PubMed ID: 30530834
[TBL] [Abstract][Full Text] [Related]
7. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
[TBL] [Abstract][Full Text] [Related]
8. ATRA attenuate proteinuria via downregulation of TRPC6 in glomerulosclerosis rats induced by adriamycin.
Zhang L; Chen XP; Qin H; Jiang L; Qin YH
Ren Fail; 2018 Nov; 40(1):266-272. PubMed ID: 29619864
[TBL] [Abstract][Full Text] [Related]
9. Rhodojaponin II attenuates kidney injury by regulating TGF-β1/Smad pathway in mice with adriamycin nephropathy.
Qiu Y; Zhou J; Zhang H; Zhou H; Tang H; Lei C; Ye C; You C; Chen Y; Wang Y; Xiong J; Su H; Yao G; Zhang C
J Ethnopharmacol; 2019 Oct; 243():112078. PubMed ID: 31301369
[TBL] [Abstract][Full Text] [Related]
10. Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria.
Liang X; Schnaper HW; Matsusaka T; Pastan I; Ledbetter S; Hayashida T
PLoS One; 2016; 11(5):e0155534. PubMed ID: 27187580
[TBL] [Abstract][Full Text] [Related]
11. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
12. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
[TBL] [Abstract][Full Text] [Related]
13. The polysaccharide fraction of Propionibacterium acnes modulates the development of experimental focal segmental glomerulosclerosis.
Reis VO; Silva JC; Souza GT; Semedo P; Buscariollo B; Pereira RL; Cenedeze MA; Pacheco-Silva A; Longo-Maugéri IM; Câmara NO; Keller AC
Immunobiology; 2012 Sep; 217(9):831-41. PubMed ID: 22257707
[TBL] [Abstract][Full Text] [Related]
14. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
Haraguchi M; Border WA; Huang Y; Noble NA
Kidney Int; 2001 Jun; 59(6):2146-55. PubMed ID: 11380816
[TBL] [Abstract][Full Text] [Related]
15. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
[TBL] [Abstract][Full Text] [Related]
16. Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice.
Blush J; Lei J; Ju W; Silbiger S; Pullman J; Neugarten J
Kidney Int; 2004 Dec; 66(6):2148-54. PubMed ID: 15569304
[TBL] [Abstract][Full Text] [Related]
17. TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Das F; Kasinath BS; Ghosh-Choudhury N; Ghosh Choudhury G
J Biol Chem; 2020 Oct; 295(42):14262-14278. PubMed ID: 32732288
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
19. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
Ma LJ; Jha S; Ling H; Pozzi A; Ledbetter S; Fogo AB
Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
